복부수술후 감염 예방에 대한 Levofloxacin(Cravit®)의 안전성과 유효성에 관한 연구
채윤석 ; 최진섭 ; 김병로 ; 이우정 ; 김경식 ; 이종훈
Korean Journal of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지), Vol.5(1) : 169~173, 2001
Korean Journal of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지)
Background/Aims: For the investigation of the efficacy and safety of intravenous levofloxacin, The clinical study was carrried out in 30 patients with abdominal operation, especially in hepatobiliary and pancreatic division.
Methods: Randomly chosen patients received intravenous levofloxacin(250㎎ bid) for only 7 days. Clinical and microbiological evaluation were conducted on the day of starting and finishing levofloxacin treatmeat except for the case of combined use of antibiotics.
Results: The most commonly isolated organism was staphylococcus aureus(33%, 3/9). The overall bacteriologic eradication rate was 67%, (6/9) with clinical success rate was 96%(29/30), There were no significant dverse effects to stop the administration of the drug.
Conclusion: These results suggest that intravenous levofloxacin is effective and safe antibiotics in the fields management of abdominal operation especially in hepatobiliary and pancreas surgery.